Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Viero

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Laser nephelometer evaluation of factor IXG Ruzza, A R Lazzaro, M L Viero, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1991
Venous thrombosis and tissue plasminogen activator release deficiency: a family studyG M Patrassi, M T Sartori, M L Viero, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Fibrinolytic effect of a particular glycosaminoglycan (endoglycan) per os on normals and in patients with chronic artery diseaseG M Patrassi, A Veronesi, M T Sartori, et al.
Thrombosis Research|June 15, 1989
DDAVP effect on factor XII activity levelsG M Patrassi, M T Sartori, M L Viero, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1992
The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable stateG M Patrassi, M T Sartori, M L Viero, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Fibrinolytic effects of defibrotide in atherosclerotic patientsG M Patrassi, M T Sartori, M L Viero, et al.
Thrombosis Research|June 1, 1990
Factor XII activation after DDAVPG M Patrassi, M T Sartori, A R Lazzaro, et al.
Rheumatology International|January 1, 1995
Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus. Relationship with Raynaud's phenomenon, disease activity, inflammatory indices, anticardiolipin antibodies and corticosteroid therapyA Doria, A Ghirardello, M Boscaro, et al.
Thrombosis Research|June 1, 1992
Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factorG M Patrassi, M T Sartori, A Casonato, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Laser nephelometer evaluation of factor IXG Ruzza, A R Lazzaro, M L Viero, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1991
Venous thrombosis and tissue plasminogen activator release deficiency: a family studyG M Patrassi, M T Sartori, M L Viero, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Fibrinolytic effect of a particular glycosaminoglycan (endoglycan) per os on normals and in patients with chronic artery diseaseG M Patrassi, A Veronesi, M T Sartori, et al.
Thrombosis Research|June 15, 1989
DDAVP effect on factor XII activity levelsG M Patrassi, M T Sartori, M L Viero, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1992
The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable stateG M Patrassi, M T Sartori, M L Viero, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Fibrinolytic effects of defibrotide in atherosclerotic patientsG M Patrassi, M T Sartori, M L Viero, et al.
Thrombosis Research|June 1, 1990
Factor XII activation after DDAVPG M Patrassi, M T Sartori, A R Lazzaro, et al.
Rheumatology International|January 1, 1995
Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus. Relationship with Raynaud's phenomenon, disease activity, inflammatory indices, anticardiolipin antibodies and corticosteroid therapyA Doria, A Ghirardello, M Boscaro, et al.
Thrombosis Research|June 1, 1992
Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factorG M Patrassi, M T Sartori, A Casonato, et al.
Pageof 1